These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 8673635)
1. [Liver mechanisms for the elimination of lipoproteins of intestinal origin]. Khallou J; Troussard AA; Masson M; Delplanque B; Mann CJ; André P; Yen FT; Bihain BE C R Seances Soc Biol Fil; 1995; 189(5):899-904. PubMed ID: 8673635 [TBL] [Abstract][Full Text] [Related]
2. Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein. Yen FT; Mann CJ; Guermani LM; Hannouche NF; Hubert N; Hornick CA; Bordeau VN; Agnani G; Bihain BE Biochemistry; 1994 Feb; 33(5):1172-80. PubMed ID: 7509190 [TBL] [Abstract][Full Text] [Related]
3. Lipolysis-stimulated receptor: a newcomer on the lipoprotein research scene. Bihain BE; Delplanque B; Khallou J; Chevreuil O; Troussard AA; Michel L; Mann CJ; Yen FT Diabete Metab; 1995 Apr; 21(2):121-6. PubMed ID: 7621972 [TBL] [Abstract][Full Text] [Related]
4. Lactoferrin and its hydrolysate bind directly to the oleate-activated form of the lipolysis stimulated lipoprotein receptor. Ahmad N; Girardet JM; Akbar S; Lanhers MC; Paris C; Yen FT; Corbier C FEBS J; 2012 Dec; 279(23):4361-73. PubMed ID: 23050782 [TBL] [Abstract][Full Text] [Related]
5. Pseudo type III dyslipoproteinemia is associated with normal fibroblast lipoprotein receptor activity. Giroux LM; Cohn JS; LaMarre J; Davignon J Atherosclerosis; 1997 Jul; 132(1):85-94. PubMed ID: 9247363 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of activation and functional significance of the lipolysis-stimulated receptor. Evidence for a role as chylomicron remnant receptor. Mann CJ; Khallou J; Chevreuil O; Troussard AA; Guermani LM; Launay K; Delplanque B; Yen FT; Bihain BE Biochemistry; 1995 Aug; 34(33):10421-31. PubMed ID: 7654696 [TBL] [Abstract][Full Text] [Related]
7. Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Hussain MM; Maxfield FR; Más-Oliva J; Tabas I; Ji ZS; Innerarity TL; Mahley RW J Biol Chem; 1991 Jul; 266(21):13936-40. PubMed ID: 1713211 [TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver. Yen FT; Masson M; Clossais-Besnard N; André P; Grosset JM; Bougueleret L; Dumas JB; Guerassimenko O; Bihain BE J Biol Chem; 1999 May; 274(19):13390-8. PubMed ID: 10224102 [TBL] [Abstract][Full Text] [Related]
9. The role of alpha 2M receptor/LRP in chylomicron remnant metabolism. Beisiegel U; Krapp A; Weber W; Olivecrona G Ann N Y Acad Sci; 1994 Sep; 737():53-69. PubMed ID: 7524435 [TBL] [Abstract][Full Text] [Related]
10. Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver. de Faria E; Fong LG; Komaromy M; Cooper AD J Lipid Res; 1996 Jan; 37(1):197-209. PubMed ID: 8820115 [TBL] [Abstract][Full Text] [Related]
11. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. Linton MF; Hasty AH; Babaev VR; Fazio S J Clin Invest; 1998 Apr; 101(8):1726-36. PubMed ID: 9541504 [TBL] [Abstract][Full Text] [Related]
12. Modulation of the low-density-lipoprotein-receptor-related protein and its relevance to chylomicron-remnant metabolism. Szanto A; Balasubramaniam S; Roach PD; Nestel PJ Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):791-4. PubMed ID: 1471994 [TBL] [Abstract][Full Text] [Related]
13. Lipolysis stimulated lipoprotein receptor: a novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice. Yen FT; Roitel O; Bonnard L; Notet V; Pratte D; Stenger C; Magueur E; Bihain BE J Biol Chem; 2008 Sep; 283(37):25650-25659. PubMed ID: 18644789 [TBL] [Abstract][Full Text] [Related]
14. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. Rohlmann A; Gotthardt M; Hammer RE; Herz J J Clin Invest; 1998 Feb; 101(3):689-95. PubMed ID: 9449704 [TBL] [Abstract][Full Text] [Related]
15. Decreased hepatic expression of the low-density lipoprotein (LDL) receptor and LDL receptor-related protein in aging rats is associated with delayed clearance of chylomicrons from the circulation. Field PA; Gibbons GF Metabolism; 2000 Apr; 49(4):492-8. PubMed ID: 10778874 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Willnow TE; Sheng Z; Ishibashi S; Herz J Science; 1994 Jun; 264(5164):1471-4. PubMed ID: 7515194 [TBL] [Abstract][Full Text] [Related]
18. [Lipoprotein receptors. Old acquaintances and newcomers]. Ducobu J Rev Med Brux; 1997 Feb; 18(1):10-5. PubMed ID: 9132912 [TBL] [Abstract][Full Text] [Related]
19. Comparison of binding and removal of remnants of triglyceride-rich lipoproteins of intestinal and hepatic origin by rat liver in vitro. Cooper AD; Shrewsbury MA; Erickson SK Am J Physiol; 1982 Nov; 243(5):G389-95. PubMed ID: 7137355 [TBL] [Abstract][Full Text] [Related]
20. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Beisiegel U; Weber W; Ihrke G; Herz J; Stanley KK Nature; 1989 Sep; 341(6238):162-4. PubMed ID: 2779654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]